Home / Community / News / News

News

10/16/2018 - 8:26am

A new study lends support for a DM biomarker panel based upon patient urine exRNA assays that may serve as a pharmacodynamic biomarker for go/no go decisions in drug development for DM1.

10/16/2018 - 8:19am

A new review looks at the cross-disease evidence for RAN translation’s contributions to pathogenesis.

09/25/2018 - 12:03pm

MDF is pleased to announce the publication of the first-ever Consensus-based Care Recommendations for Adults with Myotonic Dystrophy Type 1.

09/25/2018 - 11:16am

A new publication finds a complex mechanism of action of furamidine in DM1 models.

09/06/2018 - 6:16am

Close monitoring of respiratory function reduces respiratory complications in DM1.

Partners

ExpansionTherapeutics.png

© Myotonic Dystrophy Foundation. All rights reserved.